Treace Medical Concepts

Treace Medical Concepts

TMCI
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $216M

Market Cap: $130.9MFounded: 2013HQ: Ponte Vedra, United States

Overview

Treace Medical Concepts is a commercial-stage medical device company focused on advancing the standard of care for bunion and related midfoot surgeries through its innovative 3D procedural solutions. The company's core achievement is establishing its Lapiplasty® 3D Bunion Correction® system as a new procedural paradigm, challenging traditional 2D osteotomies. Its strategy involves expanding its comprehensive product portfolio with minimally invasive and patient-specific options, deepening surgeon training and adoption, and leveraging its commercial infrastructure to capture a significant share of the large and underserved foot and ankle deformity market.

OrthopedicsFoot & Ankle Surgery

Technology Platform

A comprehensive 3D surgical correction platform integrating proprietary instrumentation, specialized implants, and surgical methods designed to provide reproducible, anatomic correction of bunion and midfoot deformities across open and minimally invasive procedures.

Funding History

5
Total raised:$216M
IPO$146M
Series D$35M
Series C$20M
Series B$10M

Company Timeline

2013Founded

Founded in Ponte Vedra, United States

2016Series C

Series C: $20.0M

2018Series D

Series D: $35.0M

2021IPO

IPO — $146.0M